01/07/2015 07:30:25 Cookie Policy Free Membership Login

Glaxosmithkline Share Chat - GSK

Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00 +0.00% 1,322.50 1,330.00 1,330.50 - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 23,006.0 2,968.0 57.3 23.1 64,326.49

Glaxosmithkline Share Discussion Threads

DateSubjectAuthorDiscuss
30/6/2015
22:48
Think i might take a nibblebadtime
30/6/2015
17:54
Added today around 1330 - another day anther low, keep smiling )essentialinvestor
30/6/2015
17:54
Surprised at the drop - you would think this might be a safe haven in times of turbulence. Wonder where it will be tomorrow?!gswredland
30/6/2015
17:49
Don't worry guys I'll prop the price up when my buy order at 1300 gets triggered. You've gotta laughsupermarky
30/6/2015
09:38
I'm in again next week as soon as my divi arrives ..... cheap as chips .... ;0)tradermichael
30/6/2015
08:24
I'm in at this level with 6% yielddeb81e
29/6/2015
18:53
If 1300 area fails i will pull outsupermarky
29/6/2015
18:52
1300 not far off now! !supermarky
29/6/2015
16:35
Back in before the close.essentialinvestor
29/6/2015
15:36
back in this amttg100
28/6/2015
20:16
I think I will wait. It looks as though Greece is on the way out of the euro and if it does leave it will take awhile to see how its leaving will affect the rest of the EU and the world. It will be bad for Greece at least in the short term.greenpastures2
28/6/2015
11:24
On my buy list for tomorrow, depending on price.essentialinvestor
27/6/2015
16:17
sicker, it's only their view, I posted it just as a comment rather than a stated fact, which clearly it is not. Witty has 12 months, so if he does not deliver it's a new CEO and a rebased dividend - he has tended to be overoptimistic on past performance, may be this time will be different. Longer term his view on the industry will be validated, however he now needs revenue growth short term. All IMV only.essentialinvestor
27/6/2015
14:26
if Witty is no longer there his pledge I suspect will no longer be binding on the company - Given the SP performace-v- the phrma universe I would not be surprised if there is not a significant amount of II pressure building to have him replaced - However if this happens it could well (imo) be a Tony Dye moment and a signal to short the main pharma universe.pugugly
27/6/2015
14:08
ES you can choose to whom you listen. Chief executive Sir Andrew Witty said he expects the company to return to sales growth next year and pledged to maintain dividends at 80p until 2017. Who are Liberum :-} (rhetorical question)sicker
27/6/2015
13:52
Latest note from Liberum saying there is a growing threat of a dividend cut, they see this as a positive giving GSK more strategic flexibility. Agree with the first point, disagree with the second.essentialinvestor
26/6/2015
16:51
Greek situation still looking grim - keeping powder dry.tompion
26/6/2015
15:28
I am in today!spirito
26/6/2015
11:36
Difficult one tompion, good chance of a low either today or Monday, so your timing may be on the money IMV. I have a few stocks on my watch list looking tempting.essentialinvestor
26/6/2015
11:35
Toss a coin? (sorry, couldn't resist) EDIT - I am holding off for now + waiting for a re-test of Oct/Dec intra-day lowsspeedsgh
26/6/2015
11:34
Want to add to my holding but can't decide whether to do this today or wait until Monday. Could jump either way on Monday if Greek situation is resolved one way or another. Any thoughts?tompion
26/6/2015
08:30
SINGAPORE: Pharmaceutical company GlaxoSmithKline (GSK) is investing a further S$77 million to enhance its antibiotic manufacturing facility in Singapore, it announced on Thursday (Jun 25). This is on top of its initial investment of S$60 million committed in 2012. The facility on Quality Road is the company's only production site for amoxicillin, which is the active compound used in the manufacture of antibiotics that are widely prescribed for the treatment of bacterial infections. The money will be used to construct an additional downstream isolation facility for GSK's enzymatic manufacturing facility. This will increase production by 50 per cent and help GSK meet growing demand for antibiotics in emerging markets.tradermichael
24/6/2015
15:51
sorry 2015pugdog
438  437  436  435  434  433  432  431  430  429  428  427  >>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 150701 07:30